| Primary |
| Parkinson's Disease |
31.8% |
| Hypertension |
25.9% |
| Restless Legs Syndrome |
16.5% |
| Arrhythmia |
4.7% |
| Depression |
3.5% |
| Parkinsonism |
3.5% |
| Prophylaxis |
2.4% |
| Rhinitis |
2.4% |
| Back Pain |
1.2% |
| Blood Cholesterol Increased |
1.2% |
| Constipation |
1.2% |
| Diabetes Mellitus |
1.2% |
| Drug Use For Unknown Indication |
1.2% |
| Hypothyroidism |
1.2% |
| Inflammation |
1.2% |
| Pain |
1.2% |
|
| Vertigo |
14.3% |
| Pneumonia |
11.4% |
| Hypoaesthesia Facial |
8.6% |
| Lung Infection |
8.6% |
| Abortion Spontaneous |
5.7% |
| Hypertension |
5.7% |
| Obsessive-compulsive Disorder |
5.7% |
| Tuberculosis |
5.7% |
| Death |
2.9% |
| Dyskinesia |
2.9% |
| Dysphagia |
2.9% |
| Hepatitis |
2.9% |
| Insomnia |
2.9% |
| Intentional Self-injury |
2.9% |
| Intestinal Obstruction |
2.9% |
| Metabolic Encephalopathy |
2.9% |
| Mobility Decreased |
2.9% |
| Neutropenia |
2.9% |
| Oedema Peripheral |
2.9% |
| Psychotic Disorder |
2.9% |
|
| Secondary |
| Parkinson's Disease |
48.7% |
| Drug Use For Unknown Indication |
23.1% |
| Restless Legs Syndrome |
12.8% |
| Lung Neoplasm Malignant |
7.7% |
| Cognitive Disorder |
2.6% |
| Hypercholesterolaemia |
2.6% |
| Hypertension |
2.6% |
|
| Death |
13.3% |
| Therapeutic Response Unexpected |
13.3% |
| Drug Effect Decreased |
6.7% |
| Dysphagia |
6.7% |
| Metabolic Encephalopathy |
6.7% |
| Multiple Drug Overdose Intentional |
6.7% |
| Obsessive-compulsive Disorder |
6.7% |
| Parkinson's Disease |
6.7% |
| Parkinsonian Rest Tremor |
6.7% |
| Phobia |
6.7% |
| Syncope |
6.7% |
| Ventricular Tachycardia |
6.7% |
| White Blood Cell Count Increased |
6.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
32.6% |
| Parkinson's Disease |
16.2% |
| Product Used For Unknown Indication |
6.6% |
| Rheumatoid Arthritis |
6.1% |
| Hypertension |
4.7% |
| Multiple Sclerosis |
3.4% |
| Bipolar Disorder |
3.2% |
| Diffuse Large B-cell Lymphoma |
2.9% |
| Pain |
2.7% |
| Cardiac Disorder |
2.2% |
| Cough |
2.2% |
| Restless Legs Syndrome |
2.2% |
| Sleep Disorder |
2.2% |
| Anxiety |
2.0% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Pyrexia |
2.0% |
| Crohn's Disease |
1.7% |
| Depression |
1.7% |
| Diabetes Mellitus |
1.7% |
| Hepatitis C |
1.7% |
|
| Weight Decreased |
9.1% |
| Rheumatoid Arthritis |
7.3% |
| Tooth Extraction |
7.3% |
| Tooth Loss |
7.3% |
| Hepatitis Acute |
5.5% |
| Jaundice |
5.5% |
| Skin Lesion |
5.5% |
| Tachycardia |
5.5% |
| Visual Disturbance |
5.5% |
| Vomiting |
5.5% |
| Biliary Colic |
3.6% |
| Disorientation |
3.6% |
| Fluid Retention |
3.6% |
| Heart Rate Decreased |
3.6% |
| Hypertension |
3.6% |
| Nail Growth Abnormal |
3.6% |
| Nasopharyngitis |
3.6% |
| Paraesthesia |
3.6% |
| Parkinson's Disease |
3.6% |
| Rectal Haemorrhage |
3.6% |
|
| Interacting |
| Drug Use For Unknown Indication |
50.0% |
| Restless Legs Syndrome |
50.0% |
|
| Loss Of Consciousness |
100.0% |
|
